
    
      An open label, balanced, randomized, two-treatment, two-period, two-sequence, single dose,
      crossover, oral bioequivalence study of Lamotrigine Extended Release tablets 50 mg of Dr.
      Reddy's Laboratories Limited, India comparing with that of LAMICTAL XR(containing
      Lamotrigine) Extended Release tablets 50mg of GlaxoSmithKline Research Triangle Park, NC in
      healthy, adult, human subjects under fed conditions.
    
  